Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,040.00
-95.00 (-4.45%)
Nov 15, 2024, 9:00 AM KST

Kangstem Biotech Revenue

Kangstem Biotech had revenue of 2.28B KRW in the quarter ending June 30, 2024, with 96.49% growth. This brings the company's revenue in the last twelve months to 13.28B, up 12.19% year-over-year. In the year 2023, Kangstem Biotech had annual revenue of 12.70B, down -22.06%.

Revenue (ttm)
13.28B
Revenue Growth
+12.19%
P/S Ratio
7.62
Revenue / Employee
136.88M
Employees
97
Market Cap
114.35B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.70B-3.60B-22.06%
Dec 31, 202216.30B3.90B31.41%
Dec 31, 202112.40B3.27B35.75%
Dec 31, 20209.14B3.13B52.18%
Dec 31, 20196.00B-3.16B-34.49%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition